Yashoda Medicity sets cutting-edge technology in radiation oncology

ETHOS with Hypersight & Identity, 30-channel Bravos Brachytherapy and Elekta Unity MR Linac have been introduced

Yashoda Medicity, the upcoming healthcare facility by Yashoda Foundations in Indirapuram is bringing cutting-edge technology to its radiation oncology department. The introduction of three world-class advanced technologies makes Yashoda Medicity the only hospital in the Southeast Asia region equipped with such revolutionising equipment.

Varian EDGE with HyperArc for precise and targeted radiation therapy. This cutting-edge system combines high-definition imaging with advanced radiation delivery. This technology ensures that patients receive optimal doses of radiation, achieving treatment effectiveness and reducing side effects.

ETHOS with Hypersight & Identity in revolutionising radiation therapy planning with precision. By integrating real-time imaging with adaptive treatment planning, ETHOS ensures that radiation delivery is precisely aligned with the tumour's position and shape throughout the treatment course. It improves the accuracy of radiation delivery and allows for adjustments in response to changes in tumour or patient anatomy, leading to more effective and personalised treatments.

30-channel Bravos Brachytherapy system for internal radiation therapy. This advanced medical technology delivers internal radiation therapy directly to a tumour. Unlike external beam radiation therapy, which directs radiation from outside the body, brachytherapy involves placing a radiation source directly inside or close to the tumour.

Elekta Unity MR Linac represents a transformative leap in radiotherapy, integrating a 1.5T MR-Linac system that combines continuous, anatomy-specific MR imaging with comprehensive motion management for precision. Elekta Unity utilises GPU-based Monte Carlo dose calculation to model dose distribution within a magnetic field, allowing for rapid replanning in minutes and facilitating swift, informed clinical decisions based on predictive insights.
 
Dr PN Arora, Chairman, Yashoda Super Speciality Hospitals, says, “At Yashoda Medicity, we are not just building a hospital; we are shaping the future of healthcare at par with global excellence. The advanced machinery brought into the radiation oncology department will enable us to facilitate the best possible treatment for our patients with utmost care. We are proud to offer a comprehensive critical care experience backed by global best practices and an unwavering dedication to improving lives."

Dr Upasana Arora, MD/ CEO, Yashoda Super Speciality Hospitals, says, "We are committed to setting new benchmarks in healthcare through the Yashoda Medicity. The initiative will not only look after patient care by integrating cutting-edge technology and specialised expertise but also redefine the standard of health services in India."